In patients with 0-1 risk factors for coronary heart disease or in those with a calculated risk 10-year risk of CHD-related events <10%, target LDL is < 160 mg/dL.
Lifestyle modifications are recommended for those with LDL between 160 and 190 mg/dL; pharmacotherapy should be recommended in this population once LDL>190 mg/dL.
In patients with 2 or more risk factors for coronary heart disease or in those with a calculated 10-year risk of CHD-related events between 10 and 20%, target LDL is < 130 mg/dL.
Pharmacotherapy is recommended in this population to achieve the LDL goal of <130 mg/dL.
For patients with coronary heart disease or a risk-equivalent condition (peripheral vascular disease, diabetes mellitus, aortic stenosis, etc.) or 2 or more risk factors and a calculated 10-year risk of CHD-related events >20%, target LDL is < 100 mg/dL.
Pharmacotherapy is necessary in this population to achieve the LDL goal of <100 mg/dL.
Picmonic's rapid review multiple-choice quiz allows you to assess your knowledge.
*Average video play time: 2-3 minutes
Unforgettable characters with concise but impactful videos (2-4 min each)